These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6166278)

  • 1. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
    Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
    Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.
    Edy VG; Billiau A; De Somer P
    J Infect Dis; 1976 Jun; 133 Suppl():A18-21. PubMed ID: 932502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.
    Vilcek J; Sulea IT; Zerebeckyj IL; Yip YK
    J Clin Microbiol; 1980 Jan; 11(1):102-5. PubMed ID: 7354125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of human interferon-beta in monkeys.
    Hilfenhaus J; Damm H; Hofstaetter T; Mauler R; Ronneberger H; Weinmann E
    J Interferon Res; 1981; 1(3):427-36. PubMed ID: 6180075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution of human interferon in organs and tissues after its administration to man and animals].
    Maiakova SA; Berulava II; Gavrilova IE; Kuznetsov VP
    Vopr Virusol; 1980; (5):594-6. PubMed ID: 6159738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon crosses blood-cerebrospinal fluid barrier in monkeys.
    Habif DV; Lipton R; Cantell K
    Proc Soc Exp Biol Med; 1975 May; 149(1):287-9. PubMed ID: 1144440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies against human leukocyte, lymphoblastoid and fibroblast interferons elicited by immunization with human leukocyte interferon.
    Pyhälä
    Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):291-8. PubMed ID: 726897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic modifications of human fibroblast and leukocyte interferons.
    Otto MJ; Sedmak JJ; Grossberg SE
    J Virol; 1980 Aug; 35(2):390-9. PubMed ID: 6160260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating interferon in man after administration of exogenous human leukocyte interferon.
    Emödi G; Just M; Hernandez R; Hirt HR
    J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two antigenically distinct species of human interferon.
    Havell EA; Berman B; Ogburn CA; Berg K; Paucker K; Vilcek J
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2185-7. PubMed ID: 49055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of exogenous interferon in experimental animals following intratracheal administration].
    Fedorova IuB; Nekliudova LI
    Vopr Virusol; 1975; (4):416-8. PubMed ID: 1216832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of rat fibroblast interferon.
    Abreu SL
    J Pharmacol Exp Ther; 1983 Jul; 226(1):197-200. PubMed ID: 6191024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.
    Mogensen KE; Pyhälä L; Törmä E; Cantell K
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Jun; 82(3):305-10. PubMed ID: 4368958
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple active sites on human interferons.
    Paucker K; Dalton BJ; Ogburn CA; Törmä E
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4587-91. PubMed ID: 53841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and screening of cell hybrids producing a monoclonal antibody to human interferon-alpha.
    Morser J; Meager A; Burke DC; Secher DS
    J Gen Virol; 1981 Apr; 53(Pt 2):257-65. PubMed ID: 6167666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating interferon in rabbits after administration of human interferon by different routes.
    Cantell K; Pyhälä L
    J Gen Virol; 1973 Jul; 20(1):97-104. PubMed ID: 4356685
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of spleen in the interferon-lowering action of morphine.
    Geber WF; Lefkowitz SS; Hung CY
    Gen Pharmacol; 1976 Sep; 7(4):255-8. PubMed ID: 976739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of exogenous interferon on the peripheral white blood cell count in mice.
    Degré M
    Int J Cancer; 1974 Dec; 14(6):699-703. PubMed ID: 4463167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of interferon in venous blood draining from gut-associated lymphoid tissue.
    Bocci V; Paulesu L; Muscettola M; Vanni L
    Immunol Lett; 1986 Jan; 12(1):25-9. PubMed ID: 2420714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.